Tag Archives: MSKCC

June, 2017

• 1 June

  Philips and MSK Enter Partnership on Genome Analytics for Prostate Cancer Precision Medicine

  

  AMSTERDAM and NEW YORK, June 1, 2017 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Memorial Sloan Kettering Cancer Center (MSK), the world’s oldest and largest private cancer center, today announced a research collaboration to help improve the understanding of pancreatic cancer and …

  Share

  • Facebook
  • Twitter
  • LinkedIn

January, 2016

• 5 January

  New Blood Test Technology Promising for Guiding Treatment Decisions in Prostate Cancer

  

  ALEXANDRIA, Va. – An early study suggests that an experimental new blood test may help guide individualized decisions on the most appropriate treatments for patients with prostate cancer. The new non-invasive “liquid biopsy” scans the entire landscape of different kinds of cancer cells in blood and analyzes their appearance (e.g., …

  Share

  • Facebook
  • Twitter
  • LinkedIn